Literature DB >> 26038151

Anticancer effects of traditional Chinese herbs with phlegm-eliminating properties - An overview.

Li-Juan Xiu1, Da-Zhi Sun1, Jian-Peng Jiao1, Bing Yan1, Zhi-Feng Qin1, Xuan Liu1, Pin-Kang Wei2, Xiao-Qiang Yue3.   

Abstract

ETHONOPHARMACOLOGICAL RELEVANCE: Cancer is considered to be the second leading cause of human death. It is unsatisfactory that in the past decades, the treatment for cancer has not progressed as fast as it was expected, as only 50% of newly diagnosed patients could be cured even today. The development of cancer is a multifactorial process, involving tumor cells themselves, the interactions between tumor cells and their microenvironments, as well as the interactions between tumor cells and the host's immunity. Focusing on any single goal may bring limited benefits. AIM AND METHODS OF THE STUDY: Phlegm-eliminating herbs, which can reduce phlegm and eliminate pathological metabolites, are commonly used to treat cancer in China. However, the underlying molecular targets and efficacy of herbal medicines in cancer treatment still remain unclear. In this study, we reviewed the potential anticancer mechanisms of some phlegm-eliminating herbs and their active ingredients from the articles through such scientific databases as MEDLINE, PubMed, and Google Scholar.
RESULTS: We found that the anticancer mechanisms of phlegm-eliminating herbs and ingredients include inducing apoptosis, anti-proliferation, preventing tumor invasion and metastasis, and reducing resistance to chemotherapy. In addition, some phlegm-eliminating herbs and their ingredients have anti-inflammatory and anti-metabolic syndrome effects.
CONCLUSIONS: We suggest that the phlegm-eliminating herbs and ingredients are potential candidates for anticancer treatment and cancer prevention by playing a comprehensive role.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3׳,4׳,3,5,6,7,8-heptamethoxyflavone (PubChem CID: 150893); Cancer; Herb; Phlegm; Traditional Chinese medicine; deapioplatycodin D (PubChem CID: 86578026); glycoprotein (PubChem CID: 439212); hesperidin (PubChem CID: 10621); limonin (PubChem CID: 179651); nobiletin (PubChem CID: 72344); platycodin D (PubChem CID: 162859); tangeretin (PubChem CID: 68077); verticinone (PubChem CID: 167691)

Mesh:

Substances:

Year:  2015        PMID: 26038151     DOI: 10.1016/j.jep.2015.05.032

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  In vitro cytotoxic screening of 31 crude extracts of Thai herbs on a chondrosarcoma cell line and primary chondrocytes and apoptotic effects of selected extracts.

Authors:  Napat Ruamrungsri; Puntita Siengdee; Korawan Sringarm; Siriwadee Chomdej; Siriwan Ongchai; Korakot Nganvongpanit
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-02-08       Impact factor: 2.416

2.  Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts.

Authors:  Zhen-Fei Wang; Da-Guang Ma; Ling Wang; Li Feng; Jian-Wei Fu; Ying Li; Dan-Ting Wang; Yong-Feng Jia
Journal:  Chin J Integr Med       Date:  2018-10-25       Impact factor: 1.978

Review 3.  Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.

Authors:  Cong Liu; Jia-Zhi Liao; Pei-Yuan Li
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

4.  ZiYinHuaTan Recipe Inhibits Cell Proliferation and Promotes Apoptosis in Gastric Cancer by Suppressing PI3K/AKT Pathway.

Authors:  Jiahui Yu; Shangjin Song; Jianpeng Jiao; Xuan Liu; Huirong Zhu; Lijuan Xiu; Dazhi Sun; Qi Li; Xiaoqiang Yue
Journal:  Biomed Res Int       Date:  2020-04-22       Impact factor: 3.411

5.  Suppressive effect of platycodin D on bladder cancer through microRNA-129-5p-mediated PABPC1/PI3K/AKT axis inactivation.

Authors:  Dayin Chen; Tingyu Chen; Yingxue Guo; Chennan Wang; Longxin Dong; Chunfeng Lu
Journal:  Braz J Med Biol Res       Date:  2021-01-15       Impact factor: 2.904

Review 6.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

7.  Chinese Marine Materia Medica Resources: Status and Potential.

Authors:  Xiu-Mei Fu; Meng-Qi Zhang; Chang-Lun Shao; Guo-Qiang Li; Hong Bai; Gui-Lin Dai; Qian-Wen Chen; Wei Kong; Xian-Jun Fu; Chang-Yun Wang
Journal:  Mar Drugs       Date:  2016-03-03       Impact factor: 5.118

8.  Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR.

Authors:  Ting Ma; Rui-Ping Wang; Xi Zou
Journal:  BMC Complement Altern Med       Date:  2016-09-30       Impact factor: 3.659

Review 9.  Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses.

Authors:  Han Huang; Jiansong Fang; Xiude Fan; Tatsunori Miyata; Xiaoyue Hu; Lihe Zhang; Liangren Zhang; Yimin Cui; Zhenming Liu; Xiaoqin Wu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

10.  Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.

Authors:  Fabia De Oliveira Andrade; Wei Yu; Xiyuan Zhang; Elissa Carney; Rong Hu; Robert Clarke; Kevin FitzGerald; Leena Hilakivi-Clarke
Journal:  Endocr Relat Cancer       Date:  2019-03-01       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.